Karin J. Metzner

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 31 papers. Top paper: “Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study”.

Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae014

N/A

1.3DataRank · unranked

42 citations

Jessy J. Duran Ramirez, Maxime Hentzien, Matthias Cavassini, Enos Bernasconi, Eveline Hofmann +55 more

Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy

Clinical Infectious Diseases(2023)10.1093/cid/ciad286

N/A

0.590DataRank · unranked

50 citations

Frédérique Chammartin, José Damas, Alexandra Calmy, David Haerry, M Stöckle +54 more

Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV‐1 Infection

Biotechnology Journal(2020)10.1002/biot.202000023

N/A

0.494DataRank · unranked

26 citations

Alexandre Juillerat, Yik Lim Kok, Markus Hildenbeutel, Manuel Rhiel, Geoffroy Andrieux +9 more

Targeted shock-and-kill HIV-1 gene therapy approach combining CRISPR activation, suicide gene tBid and retargeted adenovirus delivery

Gene Therapy(2023)10.1038/s41434-023-00413-1

N/A

0.494DataRank · unranked

26 citations

Corinne D Schenkel, Patrick C. Freitag, Huldrych F. Gunthard, Andreas Plückthun, Karin J. Metzner +1 more

Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1

Journal of Antimicrobial Chemotherapy(2023)10.1093/jac/dkac430

N/A

0.442DataRank · unranked

18 citations

Tom Loosli, Maryam Zaheri, Paul Frischknecht, Michael Huber, Katharina Kusejko +19 more

External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

Journal of Hepatology(2023)10.1016/j.jhep.2022.12.029

N/A

0.434DataRank · unranked

17 citations

Adrià Ramírez Mena, Marie Roumet, Andreas Limacher, Colette Smit, Olivier Leleux +91 more

Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study

Clinical Infectious Diseases(2023)10.1093/cid/ciad033

N/A

0.371DataRank · unranked

8 citations

Julia N Kleynhans, Bruno Ledergerber, Isabella C Schoepf, Christian W. Thorball, Neeltje A. Kootstra +57 more

Viral and Immune Risk Factors of HIV Rebound After Interruption of Antiretroviral Therapy

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae585

N/A

0.247DataRank · unranked

3 citations

Tingting Yu, Ran Wang, Caroline Ignacio, Merle Schanz, Roger D. Kouyos +11 more

Self-reported neurocognitive complaints in the Swiss HIV Cohort Study: a viral genome-wide association study

Brain Communications(2024)10.1093/braincomms/fcae188

N/A

0.208DataRank · unranked

3 citations

Chloé Pasin, Matthias Cavassini, Mélanie Bieler-Aeschlimann, Paul Frischknecht, Katharina Kusejko +60 more

Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae291

N/A

0.208DataRank · unranked

3 citations

Frédérique Chammartin, Annette Audigé, Anna Eichenberger, Dominique L. Braun, Patrizia Amico +84 more

Transcriptional profile of Mycobacterium tuberculosis infection in people living with HIV

iScience(2024)10.1016/j.isci.2024.111228

N/A

0.165DataRank · unranked

2 citations

Lisa Jörimann, Corinne D Schenkel, Lennart Opitz, Jasmin Tschumi, Rebekka Wolfensberger +21 more

Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL’HIV Trial

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae618

N/A

0.104DataRank · unranked

1 citations

Delphine Sculier, Gilles Wandeler, Sabine Yerly, Marcel Stoeckle, Enos Bernasconi +16 more

Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

Cell Reports Methods(2023)10.1016/j.crmeth.2023.100485

N/A

0DataRank · unranked

4 citations

Yuepeng Zhang, Julian Spagnuolo, Alexander Thielen, Martin Däumer, Carsten Wiethe +58 more

Mycobacterium tuberculosis infection associated immune perturbations correlate with antiretroviral immunity

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.14.548872

N/A

0DataRank · unranked

1 citations

Lisa Jörimann, Corinne D Schenkel, Lennart Opitz, Jasmin Tschumi, Rebekka Wolfensberger +21 more

Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies

The Journal of Experimental Medicine(2024)10.1084/jem.20240365

N/A

0DataRank · unranked

39 citations

Nina K. Mair, Irène A. Abela, Kevin Groen, Roger Kuratli, Marie Lork +59 more

Circulating HBV RNA and Hepatitis B Core–Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae189

N/A

0DataRank · unranked

2 citations

Anders Boyd, Marie‐Laure Plissonnier, Barbara Testoni, Luisa Salazar‐Vizcaya, Franziska Suter‐Riniker +60 more

Using viral diversity to identify HIV-1 variants under HLA-dependent selection in a systematic viral genome-wide screen

PLoS Pathogens(2024)10.1371/journal.ppat.1012385

N/A

0DataRank · unranked

2 citations

Marius Zeeb, Christian W. Thorball, Jacques Fellay, Karin J. Metzner, Paul Frischknecht +15 more

Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae002

N/A

0DataRank · unranked

0 citations

Anthony Hauser, Magdalena Schwarzmüller, Chloé Pasin, Katharina Kusejko, Selina Epp +62 more

HIV-1 promoter is gradually silenced when integrated into BACH2 in Jurkat T-cells

PeerJ(2020)10.7717/peerj.10321

N/A

0DataRank · unranked

6 citations

Yik Lim Kok, Lisa Jörimann, Audrey Kelley, Kathrin Neumann, Daniel Heinzer +3 more

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

Cell Host & Microbe(2025)10.1016/j.chom.2025.01.004

N/A

0DataRank · unranked

3 citations

Marius Zeeb, Peter Rusert, Chloé Pasin, Jennifer L. Mamrosh, Samuel Mundia Kariuki +33 more

Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor–Based Antiretroviral Treatment

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1614

N/A

0DataRank · unranked

44 citations

Alexandra Scherrer, Roger D. Kouyos, Michael Huber, Hans H. Hirsch, Matthieu Perreau +49 more

HIV-1 promoter is gradually silenced when integrated into BACH2

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.30.011395

N/A

0DataRank · unranked

3 citations

Yik Lim Kok, Lisa Jörimann, Audrey Kelley, Kathrin Neumann, Daniel Heinzer +3 more

Clinically relevant CCR5 editing in primary CD4+ T cells with TALEN confers resistance to HIV-1 infection

(2020)10.22541/au.158990011.12602649

N/A

0DataRank · unranked

0 citations

Alexandre Juillerat, Yik Lim Kok, Markus Hildenbeutel, Manuel Rhiel, Geoffroy Andrieux +9 more

Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab032

N/A

0DataRank · unranked

28 citations

Matthias Cavassini, Marie Paule Schneider, Hansjakob Furrer, Alexandra Calmy, Manuel Battegay +51 more

HIV-1 integration sites in CD4+ T cells during primary, chronic, and late presentation of HIV-1 infection

JCI Insight(2021)10.1172/jci.insight.143940

N/A

0DataRank · unranked

21 citations

Valentina Vongrad, Sandra E Chaudron, Mohaned Shilaih, Christine Leemann, Kathrin Neumann +8 more

Coronary Artery Disease–Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study

Clinical Infectious Diseases(2021)10.1093/cid/ciab521

N/A

0DataRank · unranked

13 citations

Christian W. Thorball, Bruno Ledergerber, Tanja Engel, Marieke Raffenberg, Neeltje A. Kootstra +65 more

Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group

Clinical Infectious Diseases(2021)10.1093/cid/ciab628

N/A

0DataRank · unranked

7 citations

Benjamin Hampel, David García Núñez, Manuel Battegay, Anna Hachfeld, Enos Bernasconi +56 more

Dolutegravir Monotherapy as Maintenance Strategy: A Meta-Analysis of Individual Participant Data From Randomized Controlled Trials

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac107

N/A

0DataRank · unranked

15 citations

Laurent Hocqueloux, Dominique L. Braun, Karin J. Metzner, Roger D. Kouyos, François Raffi +9 more

Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland

The Lancet Regional Health - Europe(2023)10.1016/j.lanepe.2023.100793

N/A

0DataRank · unranked

51 citations

Susana Alves Saldanha, Fabian Schaller, Eva Choong, Aline Munting, Matthias Cavassini +65 more

Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad292

N/A

0DataRank · unranked

12 citations

Jasmin Tschumi, Marius Zeeb, Christine Leemann, Corinne D Schenkel, Kathrin Neumann +12 more

Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad150

N/A

0DataRank · unranked

9 citations

Frédérique Chammartin, Irène A. Abela, Patrizia Amico, Marcel Stoeckle, Anna Eichenberger +85 more